Soluble epoxide hydrolase inhibitors and cardiovascular diseases.
Wang ZH, Davis BB, Jiang DQ, Zhao TT, Xu DY.
Curr Vasc Pharmacol · research support, non-u.s. gov't; review; journal article · DOI 10.2174/157016113804547593 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för EET. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
12 hitsTargeting soluble epoxide hydrolase for inflammation and pain - an overview of pharmacology and the inhibitors.
Pillarisetti S, Khanna I.
Inflamm Allergy Drug Targets · review; journal article · DOI 10.2174/187152812800392823Increased EETs participate in peripheral endothelial dysfunction of cirrhosis.
Sacerdoti D, Mania D, Jiang H, Pesce P, Gaiani S, Gatta A, Bolognesi M.
Prostaglandins Other Lipid Mediat · research-article; journal article · DOI 10.1016/j.prostaglandins.2011.12.008Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury.
Zhao G, Wang J, Xu X, Jing Y, Tu L, Li X, Chen C, Cianflone K, Wang P, Dackor RT, Zeldin DC, Wang DW.
J Lipid Res · research support, n.i.h., intramural; research support, non-u.s. gov't; research-article; journal article · DOI 10.1194/jlr.m017319Epoxides and soluble epoxide hydrolase in cardiovascular physiology.
Imig JD.
Physiol Rev · research-article; review; journal article · DOI 10.1152/physrev.00021.2011Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer.
Wang D, Dubois RN.
J Clin Invest · article-commentary; comment; research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1172/jci61453Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.
Panigrahy D, Edin ML, Lee CR, Huang S, Bielenberg DR, Butterfield CE, Barnés CM, Mammoto A, Mammoto T, Luria A, Benny O, Chaponis DM, Dudley AC, Greene ER, Vergilio JA, Pietramaggiori G, Scherer-Pietramaggiori SS, Short SM, Seth M, Lih FB, Tomer KB, Yang J, Schwendener RA, Hammock BD, Falck JR, Manthati VL, Ingber DE, Kaipainen A, D'Amore PA, Kieran MW, Zeldin DC.
J Clin Invest · research support, n.i.h., intramural; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1172/jci58128Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.
Elmarakby AA.
Am J Physiol Regul Integr Comp Physiol · historical article; research support, non-u.s. gov't; review; journal article · DOI 10.1152/ajpregu.00606.2011Epoxyeicosatrienoic acids and heme oxygenase-1 interaction attenuates diabetes and metabolic syndrome complications.
Burgess A, Vanella L, Bellner L, Schwartzman ML, Abraham NG.
Prostaglandins Other Lipid Mediat · research-article; review; journal article · DOI 10.1016/j.prostaglandins.2011.10.002Soluble epoxide hydrolase and ischemic cardiomyopathy.
Zhao TT, Wasti B, Xu DY, Shen L, Du JQ, Zhao SP.
Int J Cardiol · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.ijcard.2011.05.067Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
Nithipatikom K, Moore JM, Isbell MA, Falck JR, Gross GJ.
Am J Physiol Heart Circ Physiol · comparative study; journal article; research support, n.i.h., extramural · DOI 10.1152/ajpheart.00071.2006Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.
Spector AA, Fang X, Snyder GD, Weintraub NL.
Prog Lipid Res · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; review; journal article · DOI 10.1016/s0163-7827(03)00049-3